181 related articles for article (PubMed ID: 33707521)
1. Molecular imaging of a fluorescent antibody against epidermal growth factor receptor detects high-grade glioma.
Zhou Q; Vega Leonel JCM; Santoso MR; Wilson C; van den Berg NS; Chan CT; Aryal M; Vogel H; Cayrol R; Mandella MJ; Schonig F; Lu G; Gambhir SS; Moseley ME; Rosenthal EL; Grant GA
Sci Rep; 2021 Mar; 11(1):5710. PubMed ID: 33707521
[TBL] [Abstract][Full Text] [Related]
2. EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial.
Zhou Q; van den Berg NS; Rosenthal EL; Iv M; Zhang M; Vega Leonel JCM; Walters S; Nishio N; Granucci M; Raymundo R; Yi G; Vogel H; Cayrol R; Lee YJ; Lu G; Hom M; Kang W; Hayden Gephart M; Recht L; Nagpal S; Thomas R; Patel C; Grant GA; Li G
Theranostics; 2021; 11(15):7130-7143. PubMed ID: 34158840
[No Abstract] [Full Text] [Related]
3. Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging.
Zhou Q; van den Berg NS; Kang W; Pei J; Nishio N; van Keulen S; Engelen MA; Lee YJ; Hom M; Vega Leonel JCM; Hart Z; Vogel H; Cayrol R; Martin BA; Roesner M; Shields G; Lui N; Gephart MH; Raymundo RC; Yi G; Granucci M; Grant GA; Li G; Rosenthal EL
J Nucl Med; 2022 Nov; 63(11):1693-1700. PubMed ID: 35332092
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor-targeted radioimmunotherapy of human head and neck cancer xenografts using 90Y-labeled fully human antibody panitumumab.
Liu Z; Liu Y; Jia B; Zhao H; Jin X; Li F; Chen X; Wang F
Mol Cancer Ther; 2010 Aug; 9(8):2297-308. PubMed ID: 20682654
[TBL] [Abstract][Full Text] [Related]
5. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.
Heath CH; Deep NL; Sweeny L; Zinn KR; Rosenthal EL
Ann Surg Oncol; 2012 Nov; 19(12):3879-87. PubMed ID: 22669455
[TBL] [Abstract][Full Text] [Related]
6. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival.
Kiviniemi A; Gardberg M; Frantzén J; Parkkola R; Vuorinen V; Pesola M; Minn H
J Neurooncol; 2015 Sep; 124(2):237-45. PubMed ID: 26033547
[TBL] [Abstract][Full Text] [Related]
8. PET of EGFR antibody distribution in head and neck squamous cell carcinoma models.
Niu G; Li Z; Xie J; Le QT; Chen X
J Nucl Med; 2009 Jul; 50(7):1116-23. PubMed ID: 19525473
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of affibody, panitumumab, and EGF for near-infrared fluorescence imaging of EGFR- and EGFRvIII-expressing tumors.
Gong H; Kovar JL; Cheung L; Rosenthal EL; Olive DM
Cancer Biol Ther; 2014 Feb; 15(2):185-93. PubMed ID: 24100437
[TBL] [Abstract][Full Text] [Related]
10. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
Bale TA; Jordan JT; Rapalino O; Ramamurthy N; Jessop N; DeWitt JC; Nardi V; Alvarez MM; Frosch M; Batchelor TT; Louis DN; Iafrate AJ; Cahill DP; Lennerz JK
Neuro Oncol; 2019 May; 21(5):596-605. PubMed ID: 30496526
[TBL] [Abstract][Full Text] [Related]
11. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
[TBL] [Abstract][Full Text] [Related]
12. Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.
Thorarinsdottir HK; Santi M; McCarter R; Rushing EJ; Cornelison R; Jales A; MacDonald TJ
Clin Cancer Res; 2008 Jun; 14(11):3386-94. PubMed ID: 18519768
[TBL] [Abstract][Full Text] [Related]
13. Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to
Aghevlian S; Lu Y; Winnik MA; Hedley DW; Reilly RM
Mol Pharm; 2018 Mar; 15(3):1150-1159. PubMed ID: 29314858
[TBL] [Abstract][Full Text] [Related]
14. Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice.
Heath CH; Deep NL; Beck LN; Day KE; Sweeny L; Zinn KR; Huang CC; Rosenthal EL
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):982-90. PubMed ID: 23525846
[TBL] [Abstract][Full Text] [Related]
15. In vitro neurosphere formation correlates with poor survival in glioma.
C Jayakrishnan P; H Venkat E; M Ramachandran G; K Kesavapisharady K; N Nair S; Bharathan B; Radhakrishnan N; Gopala S
IUBMB Life; 2019 Feb; 71(2):244-253. PubMed ID: 30393962
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of panitumumab-IRDye800 conjugate as a fluorescence imaging probe for EGFR-expressing cancers.
Bhattacharyya S; Patel N; Wei L; Riffle LA; Kalen JD; Hill GC; Jacobs PM; Zinn KR; Rosenthal E
Medchemcomm; 2014 Sep; 5(9):1337-1346. PubMed ID: 25431648
[TBL] [Abstract][Full Text] [Related]
17. MRI-coupled fluorescence tomography quantifies EGFR activity in brain tumors.
Davis SC; Samkoe KS; O'Hara JA; Gibbs-Strauss SL; Payne HL; Hoopes PJ; Paulsen KD; Pogue BW
Acad Radiol; 2010 Mar; 17(3):271-6. PubMed ID: 20152724
[TBL] [Abstract][Full Text] [Related]
18. In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores.
Sano K; Mitsunaga M; Nakajima T; Choyke PL; Kobayashi H
Breast Cancer Res; 2012; 14(2):R61. PubMed ID: 22510481
[TBL] [Abstract][Full Text] [Related]
19. Activity of panitumumab alone or with chemotherapy in non-small cell lung carcinoma cell lines expressing mutant epidermal growth factor receptor.
Freeman DJ; Bush T; Ogbagabriel S; Belmontes B; Juan T; Plewa C; Van G; Johnson C; Radinsky R
Mol Cancer Ther; 2009 Jun; 8(6):1536-46. PubMed ID: 19509246
[TBL] [Abstract][Full Text] [Related]
20. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.
de Souza AL; Marra K; Gunn J; Samkoe KS; Hoopes PJ; Feldwisch J; Paulsen KD; Pogue BW
Mol Imaging Biol; 2017 Feb; 19(1):41-48. PubMed ID: 27379987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]